The safety of probiotics: Considerations following the 2011 U.S. agency for health research and quality report

Journal of Nutrition

Volumn 141, Issue 11, 2011, Pages 1923-1924

  Wallace, Taylor C ^a   MacKay, Douglas ^a  

^a International and Scientific Affairs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BACILLUS; BIFIDOBACTERIUM; ENTEROCOCCUS; HEALTH CARE ORGANIZATION; LACTOBACILLUS; NONHUMAN; NOTE; PROPHYLAXIS; RISK BENEFIT ANALYSIS; RISK REDUCTION; SACCHAROMYCES; SAFETY; STREPTOCOCCUS;

EVIDENCE-BASED PRACTICE; HUMANS; PROBIOTICS; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 81055149735     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.147629     Document Type: Note

References (4)

1. Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JNV, Suttorp MJ, Johnsen B, Shanman R, Slusser W, Fu N, et al. Safety of probiotics to reduce risk and prevent or treat disease. Evidence-based practice center under contract no. 11-E007. Rockville (MD). Agency for Healthcare Research and Quality; 2011 [cited July 1, 2011]. Available from: www.ahrq.gov/clinic/tp/probiotictp.htm.
2. Whelan K, Myers CE. Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr. 2010;91: 687-703.
3. Salminen MK, Tynkkynen S, Hilpi R, Maija S, Martti V, Ruutu P, Seppo S, Ville V, Asko J. Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis. 2002;35:1155-60.
4. Blumberg J, Heaney RP, Huncharek M, Scholl T, Stampfer M, Vieth R, Weaver CM, Zeisel SH. Evidence-based criteria in the nutritional context. Nutr Rev. 2010;68:478-84.